Top Ten Reports
 |
How Will New Entrants Alter the Biologics Landscape in Ankylosing Spondylitis and Psoriatic Arthritis? A European Physician and Payer Perspective
European Physician & Payer Forum, December 2011
|
 |
Physician and Payer Perspectives on the Market for Injectable Antidiabetics in China and South Korea
Emerging Markets Physician and Payer Forum, December 2011
|
 |
Oncology Patient Flow Model: Renal Cell Carcinoma
Patient Flow Models, December 2011
|
 |
Unipolar Depression (Event-Driven)
Pharmacor, 2012 |
 |
Non-Small-Cell Lung Cancer in Russia
Emerging Markets, December 2011 |
 |
Diabetic Complications
Pharmacor, December 2011
|
 |
Oral Therapies for Type 2 Diabetes: Physician and Payer Perspectives on the Dynamics in the Chinese and South Korean Markets
Emerging Markets Physician and Payer Forum, December 2011
|
 |
Niche Markets and Rare Diseases: Bladder Cancer
Niche Markets and Rare Diseases, December 2011
|
 |
Physician and Payer Insights on the Impact of Emerging Therapies and Generic Donepezil on the U.S. Alzheimer’s Disease Market
U.S. Physician & Payer Forum, November 2011
|
 |
Special Report: Chartbook of International Pharmaceutical Prices
Spectrum, December 2011
|
Round-Up
Register to receive Decision Resources' Round-Up, a summary email of the company's latest research, products and special offers.
Decision Resources Group companies include: